Biofrontera Warrants Valuation
| BFRIW Stock | USD 0.06 0 1.69% |
Biofrontera Warrants seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of Biofrontera Warrants from analyzing the firm fundamentals such as Return On Equity of -1.49, number of shares shorted of 2.77 K, and Profit Margin of (0.38) % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Biofrontera Warrants' price fluctuation is out of control at this time. Calculation of the real value of Biofrontera Warrants is based on 3 months time horizon. Increasing Biofrontera Warrants' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Biofrontera stock is determined by what a typical buyer is willing to pay for full or partial control of Biofrontera Warrants. Since Biofrontera Warrants is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Biofrontera Stock. However, Biofrontera Warrants' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0639 | Real 0.0613 | Hype 0.0627 | Naive 0.0424 |
The intrinsic value of Biofrontera Warrants' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Biofrontera Warrants' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Biofrontera Warrants helps investors to forecast how Biofrontera stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Biofrontera Warrants more accurately as focusing exclusively on Biofrontera Warrants' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Biofrontera Warrants' intrinsic value based on its ongoing forecasts of Biofrontera Warrants' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Biofrontera Warrants' closest peers.
Biofrontera Warrants Cash |
|
Biofrontera Valuation Trend
Analysing the historical paterns of Biofrontera Warrants' enterprise value and its market capitalization is a good way to estimate and gauge the value of Biofrontera Warrants over time and is usually enough for investors to make rational market timing decisions.
Biofrontera Warrants Total Value Analysis
Biofrontera Warrants is currently forecasted to have takeover price of 0 with market capitalization of 0, debt of 5.4 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Biofrontera Warrants fundamentals before making investing decisions based on enterprise value of the companyBiofrontera Warrants Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Biofrontera Warrants has an asset utilization ratio of 121.98 percent. This indicates that the Company is making $1.22 for each dollar of assets. An increasing asset utilization means that Biofrontera Warrants is more efficient with each dollar of assets it utilizes for everyday operations.Biofrontera Warrants Profitability Analysis
The company reported the revenue of 34.07 M. Net Loss for the year was (20.13 M) with profit before overhead, payroll, taxes, and interest of 0.About Biofrontera Warrants Valuation
Our relative valuation model uses a comparative analysis of Biofrontera Warrants. We calculate exposure to Biofrontera Warrants's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Biofrontera Warrants's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 16.6 M | 14.3 M | |
| Pretax Profit Margin | (0.59) | (0.62) | |
| Operating Profit Margin | (0.67) | (0.70) | |
| Net Loss | (0.59) | (0.62) | |
| Gross Profit Margin | 0.49 | 0.54 |
Biofrontera Warrants Growth Indicators
Investing in growth stocks can be very risky. If the company such as Biofrontera Warrants does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 1.5 M |
Biofrontera Warrants Current Valuation Indicators
Valuation refers to the process of determining the present value of Biofrontera Warrants and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Biofrontera we look at many different elements of the entity such as Biofrontera's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Biofrontera Warrants, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Biofrontera Warrants' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Biofrontera Warrants' worth.Additional Tools for Biofrontera Stock Analysis
When running Biofrontera Warrants' price analysis, check to measure Biofrontera Warrants' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biofrontera Warrants is operating at the current time. Most of Biofrontera Warrants' value examination focuses on studying past and present price action to predict the probability of Biofrontera Warrants' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biofrontera Warrants' price. Additionally, you may evaluate how the addition of Biofrontera Warrants to your portfolios can decrease your overall portfolio volatility.